Biochemical markers of myocyte injury in heart failure.
This review discusses the role of biochemical markers of myocyte injury in patients with chronic congestive heart failure. Heart specific assays have been developed for the measurement of cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart type fatty acid binding protein (H-FABP), and myosin light chain 1 (MLC-1). Concentrations of these biochemical markers increase in the absence of ischaemic events in the subset of patients with heart failure whose long term outcomes are most adverse. The markers are easy to measure serially and it is therefore easy to follow patients without inter-observer variability. The serial clinical use of these markers, separately or in combination, will sharpen our understanding of the state of heart failure.
Sato
Y
Y
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaracho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. cardioys@kuhp.kyoto-u.ac.jp
Kita
T
T
Takatsu
Y
Y
Kimura
T
T
D015415:Biomarkers / Q000097:blood; D002352:Carrier Proteins / Q000097:blood; D050556:Fatty Acid-Binding Proteins; D006333:Heart Failure / Q000097:blood / Q000473:pathology*; D006801:Humans; D032383:Myocytes, Cardiac / Q000473:pathology*; D018994:Myosin Light Chains / Q000097:blood; D011379:Prognosis; D019210:Troponin I / Q000097:blood*; D020107:Troponin T / Q000097:blood*
D015415:Biomarkers; D002352:Carrier Proteins; D050556:Fatty Acid-Binding Proteins; D018994:Myosin Light Chains; D019210:Troponin I; D020107:Troponin T; C076659:myosin light chain I